Sunday, September 27, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· February 12, 2026

Orion-konsernin tilinpäätöstiedote tammi–joulukuu 2025

View original at globenewswire.com
Orion-konsernin tilinpäätöstiedote tammi–joulukuu 2025 ORION OYJ TILINPÄÄTÖSTIEDOTE 1–12/2025 12.2.2026 klo 12:00 Orion-konsernin tilinpäätöstiedote tammi–joulukuu 2025 Loka–joulukuu 2025 lyhyesti Liikevaihto oli 695,3 miljoonaa euroa (434,4 miljoonaa euroa 10–12/2024)Liikevoitto oli 328,1 (92,7) miljoonaa euroaLaiment…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 2026 revenue expected to be 1,900-2,100 million EUR

    80% confidence
  • Nubeqa has repeatedly exceeded expectations

    80% confidence
  • Orion's performance was very strong in 2025 with solid financial results and clear progress in strategy implementation

    80% confidence
  • Generics and Consumer Health sales expected to be at same level or slightly higher than 2025

    80% confidence
  • No material change expected in total investment volume in 2026 compared to 2025

    80% confidence
  • Sales and marketing expenses expected to increase in 2026

    80% confidence
  • Orion's booked annual Nubeqa sales have potential to exceed 1 billion EUR by end of current decade

    80% confidence
  • Animal Health business unit expected to grow slightly in 2026

    80% confidence
  • Q4 2025 was a strong quarter that was a great ending to successful year 2025

    80% confidence
  • ODM-212 and its mechanism of action have significant potential in different indications

    80% confidence
  • Expects another very strong year in 2026 with continued work building wellbeing and Orion's future

    80% confidence
  • Company aims to expand ODM-212 phase 2 program during 2026

    80% confidence
  • Orion's booked Nubeqa royalties and product sales expected to grow significantly in 2026

    80% confidence
  • Branded Products business unit expected to grow in 2026 with respiratory diseases therapy area and Easyhaler portfolio as growth drivers

    80% confidence
  • 2026 operating profit expected to be 550-750 million EUR

    80% confidence
  • R&D expenses expected to increase in 2026 compared to 2025

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Vertical AI Agents Attract a Funding Wave Across Fintech-Adjacent Industries
A cluster of AI-native startups applying autonomous agents to narrow, operational problems — hotel front-desk staffing (Dextr AI), identity/fraud risk for financial institutions (Baselayer), insurance distribution (Napo, Connie Health, MGT Insurance) — closed seed-to-Series A rounds within days of each other in September 2026, with CB Insights running a coordinated CEO interview series to spotlight them. The pattern points to agentic AI maturing from generic chat tools into vertical, revenue-generating products, with identity verification for AI agents themselves (Baselayer) emerging as a new fintech infrastructure category responding directly to AI-driven fraud risk.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com